Dabigatran-etexilate/warfarinHaemoptysis, haematoma and haemothorax: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1656卷 / 1期

关键词：

D O I：

10.1007/s40278-017-31499-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：169 / 169

相关论文

共 50 条

[1] Dabigatran-etexilate/rivaroxaban/warfarinHaemorrhagic complications, acute bleeding and haematoma: 3 case reports
Reactions Weekly, 2019, 1772 (1) : 122 - 122
[2] Apixaban/dabigatran-etexilate/rivaroxabanExcessive bleeding : 3 case reports
Reactions Weekly, 2022, 1920 (1) : 80 - 80
[3] Dabigatran-etexilate/rivaroxabanHaematuria, haemoptysis and melaena: 3 case reports
Reactions Weekly, 2021, 1872 (1) : 159 - 159
[4] Dabigatran-etexilate/heparinThrombocytopenia and oozing: 2 case reports
Reactions Weekly, 2021, 1854 (1) : 123 - 123
[5] Dabigatran-etexilate/primidone interactionDecrease in dabigatran-etexilate level: case report
Reactions Weekly, 2022, 1914 (1) : 177 - 177
[6] Apixaban/dabigatran-etexilate/rivaroxabanBleeding and lack of efficacy: 3 case reports
Reactions Weekly, 2024, 2028 (1) : 69 - 69
[7] Dabigatran-etexilate/warfarinVarious toxicities: 10 case reports
Reactions Weekly, 2020, 1785 (1) : 177 - 177
[8] Dabigatran-etexilate/heparin/warfarinGastrointestinal bleeding, renal haematoma and retroperitoneal bleeding: 4 case reports
Reactions Weekly, 2023, 1938 (1) : 480 - 480
[9] Aspirin/dabigatran-etexilate/rivaroxabanBleeding: 2 case reports
Reactions Weekly, 2022, 1898 (1) : 75 - 75
[10] Dabigatran etexilate/rivaroxabanGastrointestinal bleeding and haematoma: 3 case reports
Reactions Weekly, 2018, 1684 (1) : 91 - 91

← 1 2 3 4 5 →